#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14674	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2065	703.9	0	.	n	.	0	C451T	SNP	451	451	C	680	680	T	820	T,C	390,394	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14674	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2065	703.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1413	1413	C	885	C	831	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25948	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	714.8	0	.	n	.	0	T695C	SNP	695	695	T	1040	1040	C	751	C,T,G	703,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25948	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	714.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2316	2316	C	812	C,T,A	766,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25948	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	714.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2390	2390	A	815	A	778	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25948	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	714.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2942	2942	C	790	C	744	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2202	folP	855	855	100.0	folP.l15.c17.ctg.1	1448	151.2	1	SNP	p	R229S	1	.	.	685	687	AGC	964	966	AGC	226;226;231	A;G;C	211;207;205	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6062	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3261	184.9	1	SNP	p	S91F	1	.	.	271	273	TTC	552	554	TTC	206;205;205	T;T;C	196;196;192	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6062	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3261	184.9	1	SNP	p	D95G	1	.	.	283	285	GGC	564	566	GGC	193;195;194	G;G,A;C	184;184,1;182	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6062	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3261	184.9	1	SNP	p	G95N	0	.	.	283	285	GGC	564	566	GGC	193;195;194	G;G,A;C	184;184,1;182	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1670	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1320	125.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	390	392	ACC	181;181;180	A;C;C	165;173;172	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1670	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1320	125.9	0	.	p	.	0	R44H	NONSYN	130	132	CGC	405	407	CAC	181;181;181	C;A;C,T	169;167;171,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1670	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1320	125.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	588	590	CAC	215;214;215	C,T;A;C	202,1;199;203	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1670	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1320	125.9	1	SNP	p	G45D	0	.	.	133	135	GGC	408	410	GGC	181;181;184	G;G;C	171;169;173	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	906	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1001	89.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5290	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2858	184.1	1	SNP	p	D86N	0	.	.	256	258	GAC	484	486	GAC	234;236;235	G;A;C	220;215;225	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5290	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2858	184.1	1	SNP	p	R87W	0	.	.	259	261	CGT	487	489	CGT	236;233;235	C;G;T	226;222;221	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5290	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2858	184.1	1	SNP	p	S87R	1	.	.	259	261	CGT	487	489	CGT	236;233;235	C;G;T	226;222;221	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5290	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2858	184.1	1	SNP	p	R87I	0	.	.	259	261	CGT	487	489	CGT	236;233;235	C;G;T	226;222;221	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5290	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2858	184.1	1	SNP	p	S88P	0	.	.	262	264	TCC	490	492	TCC	236;232;232	T;C;C	224;220;221	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4550	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2799	161.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1587	1589	GGC	215;211;206	G;G;C	206;204;201	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1212	1214	GCC	223;226;232	G;C;C	211;213;222	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1215	1217	ATG	232;230;235	A;T;G	222;218;222	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1227	1229	ACC	237;236;240	A,G;C;C,T	219,1;223;225,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1227	1229	ACC	237;236;240	A,G;C;C,T	219,1;223;225,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1728	1730	ACC	212;212;213	A,G;C;C	192,1;198;198	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1782	1784	GCG	238;237;235	G;C;G	229;227;224	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1782	1784	GCG	238;237;235	G;C;G	229;227;224	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1905	1907	GGT	183;185;189	G;G;T	167;170;172	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1914	1916	AGC	181;179;177	A;G;C	168;169;166	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4244	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2286	184.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1932	1934	CCG	155;158;162	C,G;C,G;G	122,3;125,1;135	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5872	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3143	186.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1703	1705	CCG	222;222;220	C;C;G	193;201;194	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2432	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1619	148.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	478	478	C	176	C	163	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3056	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1618	187.8	0	.	p	.	0	G48E	NONSYN	142	144	GGA	429	431	GAA	241;245;251	G;A,G;A	226;228,2;233	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3056	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1618	187.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	915	917	AGA	277;276;276	A,G;G;A	265,1;262;261	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3056	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1618	187.8	0	.	p	.	0	S217G	NONSYN	649	651	AGT	936	938	GGT	268;270;269	G,A;G;T	252,1;259;253	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3056	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1618	187.8	1	SNP	p	G120K	1	.	.	358	360	AAG	645	647	AAG	216;217;218	A;A;G	208;209;207	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3056	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1618	187.8	1	SNP	p	N121D	0	.	.	361	363	AAC	648	650	AAC	222;224;224	A;A;C	213;217;215	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3056	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1618	187.8	1	SNP	p	A121N	1	.	.	361	363	AAC	648	650	AAC	222;224;224	A;A;C	213;217;215	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10366	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4801	215.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1082	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1038	103.7	1	SNP	p	V57M	1	.	.	169	171	ATG	588	590	ATG	248;250;248	A;T;G	235;237;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
